Your browser doesn't support javascript.
loading
Phage K exposure generates phage-neutralizing activity in a rabbit model-humoral receptiveness may impact efficacy of phage therapy.
Herren, Sebastian C; Karau, Melissa J; Koscianski, Christina A; Christensen, Trace A; Granger, Dane; Bergan, Nathanial G; Mandrekar, Jay; Holmes, David R; Patel, Robin.
Afiliação
  • Herren SC; Department of Laboratory Medicine and Pathology, Division of Clinical Microbiology, Mayo Clinic, Rochester, Minnesota, USA.
  • Karau MJ; Department of Laboratory Medicine and Pathology, Division of Clinical Microbiology, Mayo Clinic, Rochester, Minnesota, USA.
  • Koscianski CA; Department of Laboratory Medicine and Pathology, Division of Clinical Microbiology, Mayo Clinic, Rochester, Minnesota, USA.
  • Christensen TA; Department of Biochemistry and Molecular Biology, Microscopy and Cell Analysis Core Facility, Mayo Clinic, Rochester, Minnesota, USA.
  • Granger D; Department of Laboratory Medicine and Pathology, Division of Clinical Microbiology, Mayo Clinic, Rochester, Minnesota, USA.
  • Bergan NG; Department of Physiology and Biomedical Engineering, Biomedical Imaging Resource Core Facility, Mayo Clinic, Rochester, Minnesota, USA.
  • Mandrekar J; Department of Health Sciences Research, Division of Biomedical Statistics and Informatics, Mayo Clinic, Rochester, Minnesota, USA.
  • Holmes DR; Department of Physiology and Biomedical Engineering, Biomedical Imaging Resource Core Facility, Mayo Clinic, Rochester, Minnesota, USA.
  • Patel R; Department of Laboratory Medicine and Pathology, Division of Clinical Microbiology, Mayo Clinic, Rochester, Minnesota, USA.
Antimicrob Agents Chemother ; : e0005224, 2024 May 08.
Article em En | MEDLINE | ID: mdl-38717092
ABSTRACT
Phage therapy has not been established in the clinical routine, in part due to uncertainties concerning efficacy and immunogenicity. Here, three rabbits were immunized against staphylococcal phage K to assess viral potency in the presence of immunized serum. Three rabbits received weekly intramuscular injections of ~1010±1 pfu/mL phage K. Phage K-specific IgG formation was measured by an enzyme-linked immunosorbent assay (ELISA); phage inactivation was assessed by calculating K-rates. Using transmission electron microscopy (TEM) and immunogold labeling, antibody binding to phage K was visualized. This was numerically assessed by objective imaging analysis comparing the relative distances of each gold particle to the nearest phage head and tail structure. Immunization led to a strong IgG response, plateauing 7 days after the last phage injection. There was no significant correlation between K-rate and antibody titer over time. TEM showed IgG binding to the head structure of phage K. Image analysis showed a significant reduction in relative distances between antibodies and phage head structures when comparing samples from day 0 and day 28 (P < 0.0001). These results suggest that while individual serum analysis for antibodies against therapeutic phage bears consideration prior to and with prolonged therapy, during phage application, the formation of specific antibodies against phage may only partially explain decreased phage potency in the presence of immunized serum. Instead, other factors may contribute to an individual's "humoral receptiveness" to phage therapy. Future investigations should be directed toward the identification of the humoral factors that have the most significant predictive value on phage potency in vivo.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Antimicrob Agents Chemother Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Antimicrob Agents Chemother Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Estados Unidos